ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Indiana » Specialist

Top Specialist Prescribers in Indiana

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
ADOLPHUS ANEKWE M.D.

Specialist

12,677

$865K

609
387 are 65+

2%
patients receiving schedule two controlled substances

Avg: 5%

18%
patients receiving schedule three controlled substances

Avg: 16%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

31%
prescriptions for brand name drugs

Avg: 28%

$68
Average prescription price

Avg: $122

DIANE PFEIFER MD

Specialist

9,620

$653K

376
329 are 65+

0%
patients receiving schedule two controlled substances

Avg: 5%

13%
patients receiving schedule three controlled substances

Avg: 16%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

27%
prescriptions for brand name drugs

Avg: 28%

$68
Average prescription price

Avg: $122

DEMITRY ARBUCK M.D

Specialist

8,842

$1.57M

394
117 are 65+

24%
patients receiving schedule two controlled substances

Avg: 5%

69%
patients receiving schedule three controlled substances

Avg: 16%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

36%
prescriptions for brand name drugs

Avg: 28%

$177
Average prescription price

Avg: $122

PRADIP PATEL M.D.

Specialist

8,836

$570K

307
215 are 65+

0%
patients receiving schedule two controlled substances

Avg: 5%

22%
patients receiving schedule three controlled substances

Avg: 16%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

31%
prescriptions for brand name drugs

Avg: 28%

$64
Average prescription price

Avg: $122

SATISH PATEL M.D.

Specialist

8,235

$535K

342
215 are 65+

0%
patients receiving schedule two controlled substances

Avg: 5%

20%
patients receiving schedule three controlled substances

Avg: 16%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

29%
prescriptions for brand name drugs

Avg: 28%

$65
Average prescription price

Avg: $122

MADHAVI CHILAKAMARRI MD

Specialist

7,996

$496K

354
274 are 65+

8%
patients receiving schedule two controlled substances

Avg: 5%

25%
patients receiving schedule three controlled substances

Avg: 16%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

27%
prescriptions for brand name drugs

Avg: 28%

$62
Average prescription price

Avg: $122

PRIMO ANDRES MD

Specialist

6,962

$331K

444
342 are 65+

0%
patients receiving schedule two controlled substances

Avg: 5%

2%
patients receiving schedule three controlled substances

Avg: 16%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

22%
prescriptions for brand name drugs

Avg: 28%

$48
Average prescription price

Avg: $122

DOUGLAS MAZUREK M.D.

Specialist

5,812

$520K

255
181 are 65+

7%
patients receiving schedule two controlled substances

Avg: 5%

15%
patients receiving schedule three controlled substances

Avg: 16%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

29%
prescriptions for brand name drugs

Avg: 28%

$90
Average prescription price

Avg: $122

DAVID WELSH M.D.

Specialist

5,400

$202K

359
270 are 65+

3%
patients receiving schedule two controlled substances

Avg: 5%

20%
patients receiving schedule three controlled substances

Avg: 16%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

25%
prescriptions for brand name drugs

Avg: 28%

$37
Average prescription price

Avg: $122

INGRID MASON M.D.

Specialist

5,129

$342K

195
168 are 65+

0%
patients receiving schedule two controlled substances

Avg: 5%

13%
patients receiving schedule three controlled substances

Avg: 16%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

28%
prescriptions for brand name drugs

Avg: 28%

$67
Average prescription price

Avg: $122

BHAKTAVATSALA APURI M.D., FACC

Specialist

4,987

$263K

376
221 are 65+

0%
patients receiving schedule two controlled substances

Avg: 5%

6%
patients receiving schedule three controlled substances

Avg: 16%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

22%
prescriptions for brand name drugs

Avg: 28%

$53
Average prescription price

Avg: $122

BRIAN MOORE M.D.

Specialist

4,973

$722K

502
323 are 65+

0%
patients receiving schedule two controlled substances

Avg: 5%

0%
patients receiving schedule three controlled substances

Avg: 16%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

27%
prescriptions for brand name drugs

Avg: 28%

$145
Average prescription price

Avg: $122

JAMIE BALES M.D.

Specialist

4,589

$1.16M

388
237 are 65+

4%
patients receiving schedule two controlled substances

Avg: 5%

6%
patients receiving schedule three controlled substances

Avg: 16%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

30%
prescriptions for brand name drugs

Avg: 28%

$252
Average prescription price

Avg: $122

EDWARD KOWLOWITZ M.D.

Specialist

4,240

$491K

342
60 are 65+

75%
patients receiving schedule two controlled substances

Avg: 5%

38%
patients receiving schedule three controlled substances

Avg: 16%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

24%
prescriptions for brand name drugs

Avg: 28%

$116
Average prescription price

Avg: $122

KAUSALYA CHANDRASEKHAR MD

Specialist

3,868

$608K

293
155 are 65+

4%
patients receiving schedule two controlled substances

Avg: 5%

16%
patients receiving schedule three controlled substances

Avg: 16%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

20%
prescriptions for brand name drugs

Avg: 28%

$157
Average prescription price

Avg: $122

ABBOUD KAWAK M.D.

Specialist

3,784

$1.42M

424
278 are 65+

5%
patients receiving schedule two controlled substances

Avg: 5%

8%
patients receiving schedule three controlled substances

Avg: 16%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

52%
prescriptions for brand name drugs

Avg: 28%

$374
Average prescription price

Avg: $122

CHARLES REBESCO M.D.

Specialist

3,494

$661K

374
302 are 65+

0%
patients receiving schedule two controlled substances

Avg: 5%

0%
patients receiving schedule three controlled substances

Avg: 16%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

61%
prescriptions for brand name drugs

Avg: 28%

$189
Average prescription price

Avg: $122

MOAZZAM HABIB MD

Specialist

3,414

$559K

266
155 are 65+

0%
patients receiving schedule two controlled substances

Avg: 5%

5%
patients receiving schedule three controlled substances

Avg: 16%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

51%
prescriptions for brand name drugs

Avg: 28%

$164
Average prescription price

Avg: $122

SHLOMO HELLERSTEIN M.D.

Specialist

3,402

$179K

114
76 are 65+

0%
patients receiving schedule two controlled substances

Avg: 5%

42%
patients receiving schedule three controlled substances

Avg: 16%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

24%
prescriptions for brand name drugs

Avg: 28%

$53
Average prescription price

Avg: $122

VICTOR MATIBAG MD

Specialist

3,374

$537K

266
79 are 65+

0%
patients receiving schedule two controlled substances

Avg: 5%

21%
patients receiving schedule three controlled substances

Avg: 16%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

24%
prescriptions for brand name drugs

Avg: 28%

$159
Average prescription price

Avg: $122

JANET STREEPEY M.D. MPH

Specialist

3,161

$176K

191
107 are 65+

0%
patients receiving schedule two controlled substances

Avg: 5%

9%
patients receiving schedule three controlled substances

Avg: 16%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

23%
prescriptions for brand name drugs

Avg: 28%

$56
Average prescription price

Avg: $122

DEBORAH QUINTON MD

Specialist

3,097

$320K

216
85 are 65+

0%
patients receiving schedule two controlled substances

Avg: 5%

0%
patients receiving schedule three controlled substances

Avg: 16%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

20%
prescriptions for brand name drugs

Avg: 28%

$103
Average prescription price

Avg: $122

RAJA DEVANATHAN M.D.

Specialist

3,086

$569K

371
277 are 65+

0%
patients receiving schedule two controlled substances

Avg: 5%

3%
patients receiving schedule three controlled substances

Avg: 16%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

58%
prescriptions for brand name drugs

Avg: 28%

$184
Average prescription price

Avg: $122

DOUGLAS PAINE M.D.

Specialist

3,043

$685K

329
240 are 65+

0%
patients receiving schedule two controlled substances

Avg: 5%

0%
patients receiving schedule three controlled substances

Avg: 16%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

23%
prescriptions for brand name drugs

Avg: 28%

$225
Average prescription price

Avg: $122

ASHOK KADAMBI MD

Specialist

3,006

$619K

435
251 are 65+

0%
patients receiving schedule two controlled substances

Avg: 5%

8%
patients receiving schedule three controlled substances

Avg: 16%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

43%
prescriptions for brand name drugs

Avg: 28%

$206
Average prescription price

Avg: $122

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank